+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clot Management Devices Market: Global Opportunity Analysis and Industry Forecast, 2024-2035

  • PDF Icon

    Report

  • 250 Pages
  • December 2024
  • Region: Global
  • Allied Market Research
  • ID: 6053739
Description Jump to:
The Clot Management Devices Market was valued for $2.09 billion in 2023 and is estimated to reach $4.31 billion by 2035, exhibiting a CAGR of 6.2% from 2024 to 2035.

Clot management devices are medical tools designed to address blood clots that form in veins and arteries, which often lead to serious conditions such as deep vein thrombosis (DVT), pulmonary embolism, stroke, and peripheral arterial disease. These devices help to either dissolve or remove clots, restoring proper blood flow and preventing complications such as tissue damage or organ failure. Clot management devices are used in various medical settings, including interventional radiology, cardiology, and neurology. They play a critical role in emergency treatment for strokes, in managing chronic conditions such as deep vein thrombosis, and in preventing further complications in patients at high risk for clot formation.

Major factors driving the growth of clot management devices market are surge in prevalence of cardiovascular diseases, technological advancement in the clot management devices, and development in healthcare infrastructure especially in middle income countries. The rise in prevalence of cardiovascular diseases is a major driver for the clot management devices market expansion, as these conditions significantly increase the risk of blood clot formation. Cardiovascular diseases, such as coronary artery disease, atrial fibrillation, and peripheral artery disease, often lead to complications such as deep vein thrombosis, pulmonary embolism, and stroke, all of which require effective clot management solutions.

According to a 2021 article by the National Library of Medicine, coronary artery disease alone accounts for 15.5% of total deaths globally, highlighting the substantial burden of these conditions. As the incidence of cardiovascular diseases rises, driven by factors such as unhealthy lifestyles, aging populations, and increased prevalence of risk factors such as hypertension and diabetes, the demand for clot management devices continues to grow. These devices play a critical role in preventing and treating life-threatening blood clots, driving their increased adoption in clinical settings.

Furthermore, technological advancements in clot management boost the growth of the market, as they enable more precise, effective, and less invasive treatments for blood clots. Innovative devices designed for faster clot removal and enhanced patient safety have transformed the management of conditions such as deep vein thrombosis and pulmonary embolism. A notable example is the Cleaner Vac Thrombectomy System, launched by Argon Medical Devices in September 2024.

This system is a disposable, large-bore aspiration device specifically designed to remove blood clots quickly and effectively, or thrombus, from the peripheral venous vasculature. The Cleaner Vac empowers physicians with manual control overpowered aspiration, allowing for precise clot removal while minimizing the risk of vessel damage and reducing blood loss. Such advancements improve procedural efficiency and enhance patient outcomes by reducing complications and recovery times.

The continuous introduction of technologically advanced devices such as the Cleaner Vac is driving increased adoption of clot management devices in hospitals and clinics, further fueling market growth. Moreover, the development of healthcare infrastructure in middle-income countries is a crucial driver of the growth of the clot management devices market, as it significantly enhances the capacity to diagnose and treat cardiovascular diseases & thrombotic conditions.

As these countries continue to improve their healthcare systems, the demand for advanced medical technologies rises, including clot management devices. According to a 2024 article by the Press Information Bureau, Government Health Expenditure accounted for around 1.84% of the GDP of India. This substantial investment enables the expansion of healthcare facilities, including specialized hospitals and clinics that are better equipped to handle complex medical conditions.

The clot management devices market is segmented on the basis of product, end user, and region. By product, the market is classified into neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF). By end user, it is segregated into hospitals and other end user. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, Johnson & Johnson, Abbott Laboratories, AngioDynamics, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., and Koninklijke Philips N.V.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clot management devices market analysis from 2023 to 2035 to identify the prevailing clot management devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the clot management devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global clot management devices market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Product

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Type
  • Mechanical Thrombectomy
  • Type
  • Aspiration Thrombectomy
  • Type
  • Catheter-Directed Thrombolysis Devices
  • Inferior Vena Cava Filters
  • Type
  • Permanent
  • Retrieval

By End User

  • Hospitals
  • Other End Users

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Johnson and Johnson
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of thromboembolic disorders
3.4.1.2. Developing healthcare infrastructure
3.4.1.3. Growing trend towards minimally invasive surgeries
3.4.2. Restraints
3.4.2.1. High cost of clot management devices
3.4.3. Opportunities
3.4.3.1. Technological advancement in the clot management devices
CHAPTER 4: CLOT MANAGEMENT DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Neurovascular Embolectomy Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Embolectomy Balloon Catheters
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Percutaneous Thrombectomy Devices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.4.4. Percutaneous Thrombectomy Devices Clot Management Devices Market by Type
4.4.4.1. Mechanical Thrombectomy Clot Management Devices Market by Type
4.4.4.2. Aspiration Thrombectomy Clot Management Devices Market by Type
4.5. Catheter-Directed Thrombolysis Devices
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Inferior Vena Cava Filters
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.6.4. Inferior Vena Cava Filters Clot Management Devices Market by Type
CHAPTER 5: CLOT MANAGEMENT DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Other End Users
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: CLOT MANAGEMENT DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Product
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Product
6.2.4.1.2. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Product
6.2.4.2.2. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Product
6.2.4.3.2. Market size and forecast, by End User
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Product
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Product
6.3.4.1.2. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Product
6.3.4.2.2. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Product
6.3.4.3.2. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Product
6.3.4.4.2. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Product
6.3.4.5.2. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Product
6.3.4.6.2. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Product
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Market size and forecast, by Product
6.4.4.1.2. Market size and forecast, by End User
6.4.4.2. China
6.4.4.2.1. Market size and forecast, by Product
6.4.4.2.2. Market size and forecast, by End User
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Product
6.4.4.3.2. Market size and forecast, by End User
6.4.4.4. Australia
6.4.4.4.1. Market size and forecast, by Product
6.4.4.4.2. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Product
6.4.4.5.2. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Product
6.4.4.6.2. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Product
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Product
6.5.4.1.2. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Market size and forecast, by Product
6.5.4.2.2. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Market size and forecast, by Product
6.5.4.3.2. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Market size and forecast, by Product
6.5.4.4.2. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Boston Scientific Corporation
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.2. Edwards Lifesciences Corporation
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Medtronic plc
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.4. Johnson and Johnson
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. Abbott Laboratories
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. AngioDynamics, Inc.
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Stryker Corporation
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.8. Terumo Corporation
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Penumbra, Inc.
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Koninklijke Philips N.V.
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
LIST OF TABLES
Table 01. Global Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 02. Clot Management Devices Market for Neurovascular Embolectomy Devices, by Region, 2023-2035 ($Million)
Table 03. Clot Management Devices Market for Embolectomy Balloon Catheters, by Region, 2023-2035 ($Million)
Table 04. Clot Management Devices Market for Percutaneous Thrombectomy Devices, by Region, 2023-2035 ($Million)
Table 05. Global Percutaneous Thrombectomy Devices Clot Management Devices Market, by Type, 2023-2035 ($Million)
Table 06. Global Mechanical Thrombectomy Clot Management Devices Market, by Type, 2023-2035 ($Million)
Table 07. Global Aspiration Thrombectomy Clot Management Devices Market, by Type, 2023-2035 ($Million)
Table 08. Clot Management Devices Market for Catheter-Directed Thrombolysis Devices, by Region, 2023-2035 ($Million)
Table 09. Clot Management Devices Market for Inferior Vena Cava Filters, by Region, 2023-2035 ($Million)
Table 10. Global Inferior Vena Cava Filters Clot Management Devices Market, by Type, 2023-2035 ($Million)
Table 11. Global Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 12. Clot Management Devices Market for Hospitals, by Region, 2023-2035 ($Million)
Table 13. Clot Management Devices Market for Other End-users, by Region, 2023-2035 ($Million)
Table 14. Clot Management Devices Market, by Region, 2023-2035 ($Million)
Table 15. North America Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 16. North America Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 17. North America Clot Management Devices Market, by Country, 2023-2035 ($Million)
Table 18. U.S. Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 19. U.S. Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 20. Canada Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 21. Canada Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 22. Mexico Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 23. Mexico Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 24. Europe Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 25. Europe Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 26. Europe Clot Management Devices Market, by Country, 2023-2035 ($Million)
Table 27. Germany Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 28. Germany Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 29. France Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 30. France Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 31. UK Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 32. UK Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 33. Italy Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 34. Italy Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 35. Spain Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 36. Spain Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 37. Rest of Europe Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 38. Rest of Europe Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 39. Asia-Pacific Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 40. Asia-Pacific Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 41. Asia-Pacific Clot Management Devices Market, by Country, 2023-2035 ($Million)
Table 42. Japan Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 43. Japan Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 44. China Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 45. China Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 46. India Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 47. India Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 48. Australia Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 49. Australia Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 50. South Korea Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 51. South Korea Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 52. Rest of Asia-Pacific Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 53. Rest of Asia-Pacific Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 54. LAMEA Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 55. LAMEA Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 56. LAMEA Clot Management Devices Market, by Country, 2023-2035 ($Million)
Table 57. Brazil Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 58. Brazil Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 59. Saudi Arabia Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 60. Saudi Arabia Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 61. South Africa Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 62. South Africa Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 63. Rest of LAMEA Clot Management Devices Market, by Product, 2023-2035 ($Million)
Table 64. Rest of LAMEA Clot Management Devices Market, by End-user, 2023-2035 ($Million)
Table 65. Boston Scientific Corporation: Key Executives
Table 66. Boston Scientific Corporation: Company Snapshot
Table 67. Boston Scientific Corporation: Product Segments
Table 68. Boston Scientific Corporation: Product Portfolio
Table 69. Edwards Lifesciences Corporation: Key Executives
Table 70. Edwards Lifesciences Corporation: Company Snapshot
Table 71. Edwards Lifesciences Corporation: Product Segments
Table 72. Edwards Lifesciences Corporation: Product Portfolio
Table 73. Medtronic PLC: Key Executives
Table 74. Medtronic PLC: Company Snapshot
Table 75. Medtronic PLC: Product Segments
Table 76. Medtronic PLC: Product Portfolio
Table 77. Johnson and Johnson: Key Executives
Table 78. Johnson and Johnson: Company Snapshot
Table 79. Johnson and Johnson: Product Segments
Table 80. Johnson and Johnson: Product Portfolio
Table 81. Abbott Laboratories: Key Executives
Table 82. Abbott Laboratories: Company Snapshot
Table 83. Abbott Laboratories: Product Segments
Table 84. Abbott Laboratories: Product Portfolio
Table 85. Abbott Laboratories: Key Stratergies
Table 86. Angiodynamics, Inc.: Key Executives
Table 87. Angiodynamics, Inc.: Company Snapshot
Table 88. Angiodynamics, Inc.: Product Segments
Table 89. Angiodynamics, Inc.: Product Portfolio
Table 90. Angiodynamics, Inc.: Key Stratergies
Table 91. Stryker Corporation: Key Executives
Table 92. Stryker Corporation: Company Snapshot
Table 93. Stryker Corporation: Product Segments
Table 94. Stryker Corporation: Product Portfolio
Table 95. Terumo Corporation: Key Executives
Table 96. Terumo Corporation: Company Snapshot
Table 97. Terumo Corporation: Product Segments
Table 98. Terumo Corporation: Product Portfolio
Table 99. Terumo Corporation: Key Stratergies
Table 100. Penumbra, Inc.: Key Executives
Table 101. Penumbra, Inc.: Company Snapshot
Table 102. Penumbra, Inc.: Product Segments
Table 103. Penumbra, Inc.: Product Portfolio
Table 104. Penumbra, Inc.: Key Stratergies
Table 105. Koninklijke Philips N.V.: Key Executives
Table 106. Koninklijke Philips N.V.: Company Snapshot
Table 107. Koninklijke Philips N.V.: Product Segments
Table 108. Koninklijke Philips N.V.: Product Portfolio
LIST OF FIGURES
Figure 01. Clot Management Devices Market, 2023-2035
Figure 02. Segmentation of Clot Management Devices Market,2023-2035
Figure 03. Top Impacting Factors in Clot Management Devices Market (2023 to 2035)
Figure 04. Top Investment Pockets in Clot Management Devices Market (2024-2035)
Figure 05. Low Bargaining Power of Suppliers
Figure 06. Low Threat of New Entrants
Figure 07. Low Threat of Substitutes
Figure 08. Low Intensity of Rivalry
Figure 09. Low Bargaining Power of Buyers
Figure 10. Global Clot Management Devices Market:Drivers, Restraints and Opportunities
Figure 11. Clot Management Devices Market, by Product, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Clot Management Devices Market for Neurovascular Embolectomy Devices, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Clot Management Devices Market for Embolectomy Balloon Catheters, by Country 2023 and 2035(%)
Figure 14. Comparative Share Analysis of Clot Management Devices Market for Percutaneous Thrombectomy Devices, by Country 2023 and 2035(%)
Figure 15. Comparative Share Analysis of Clot Management Devices Market for Catheter-Directed Thrombolysis Devices, by Country 2023 and 2035(%)
Figure 16. Comparative Share Analysis of Clot Management Devices Market for Inferior Vena Cava Filters, by Country 2023 and 2035(%)
Figure 17. Clot Management Devices Market, by End-user, 2023 and 2035(%)
Figure 18. Comparative Share Analysis of Clot Management Devices Market for Hospitals, by Country 2023 and 2035(%)
Figure 19. Comparative Share Analysis of Clot Management Devices Market for Other End-users, by Country 2023 and 2035(%)
Figure 20. Clot Management Devices Market by Region, 2023 and 2035(%)
Figure 21. U.S. Clot Management Devices Market, 2023-2035 ($Million)
Figure 22. Canada Clot Management Devices Market, 2023-2035 ($Million)
Figure 23. Mexico Clot Management Devices Market, 2023-2035 ($Million)
Figure 24. Germany Clot Management Devices Market, 2023-2035 ($Million)
Figure 25. France Clot Management Devices Market, 2023-2035 ($Million)
Figure 26. UK Clot Management Devices Market, 2023-2035 ($Million)
Figure 27. Italy Clot Management Devices Market, 2023-2035 ($Million)
Figure 28. Spain Clot Management Devices Market, 2023-2035 ($Million)
Figure 29. Rest of Europe Clot Management Devices Market, 2023-2035 ($Million)
Figure 30. Japan Clot Management Devices Market, 2023-2035 ($Million)
Figure 31. China Clot Management Devices Market, 2023-2035 ($Million)
Figure 32. India Clot Management Devices Market, 2023-2035 ($Million)
Figure 33. Australia Clot Management Devices Market, 2023-2035 ($Million)
Figure 34. South Korea Clot Management Devices Market, 2023-2035 ($Million)
Figure 35. Rest of Asia-Pacific Clot Management Devices Market, 2023-2035 ($Million)
Figure 36. Brazil Clot Management Devices Market, 2023-2035 ($Million)
Figure 37. Saudi Arabia Clot Management Devices Market, 2023-2035 ($Million)
Figure 38. South Africa Clot Management Devices Market, 2023-2035 ($Million)
Figure 39. Rest of LAMEA Clot Management Devices Market, 2023-2035 ($Million)
Figure 40. Top Winning Strategies, by Year (2021-2024)
Figure 41. Top Winning Strategies, by Development (2021-2024)
Figure 42. Top Winning Strategies, by Company (2021-2024)
Figure 43. Product Mapping of Top 10 Players
Figure 44. Competitive Dashboard
Figure 45. Competitive Heatmap: Clot Management Devices Market
Figure 46. Top Player Positioning, 2023
Figure 47. Boston Scientific Corporation: Net Sales, 2021-2023 ($Million)
Figure 48. Boston Scientific Corporation: Revenue Share by Segment, 2023 (%)
Figure 49. Boston Scientific Corporation: Revenue Share by Region, 2023 (%)
Figure 50. Edwards Lifesciences Corporation: Net Sales, 2021-2023 ($Million)
Figure 51. Edwards Lifesciences Corporation: Revenue Share by Region, 2023 (%)
Figure 52. Edwards Lifesciences Corporation: Revenue Share by Segment, 2023 (%)
Figure 53. Medtronic PLC: Net Revenue, 2022-2024 ($Million)
Figure 54. Medtronic PLC: Revenue Share by Segment, 2024 (%)
Figure 55. Medtronic PLC: Revenue Share by Region, 2024 (%)
Figure 56. Johnson and Johnson: Net Revenue, 2021-2023 ($Million)
Figure 57. Johnson and Johnson: Revenue Share by Segment, 2023 (%)
Figure 58. Johnson and Johnson: Revenue Share by Region, 2023 (%)
Figure 59. Abbott Laboratories: Net Sales, 2021-2023 ($Million)
Figure 60. Abbott Laboratories: Revenue Share by Segment, 2023 (%)
Figure 61. Abbott Laboratories: Revenue Share by Region, 2023 (%)
Figure 62. Angiodynamics, Inc.: Net Sales, 2022-2024 ($Million)
Figure 63. Angiodynamics, Inc.: Revenue Share by Segment, 2024 (%)
Figure 64. Angiodynamics, Inc.: Revenue Share by Region, 2024 (%)
Figure 65. Stryker Corporation: Net Sales, 2021-2023 ($Million)
Figure 66. Stryker Corporation: Revenue Share by Segment, 2023 (%)
Figure 67. Stryker Corporation: Revenue Share by Region, 2023 (%)
Figure 68. Terumo Corporation: Net Sales, 2021-2023 ($Million)
Figure 69. Terumo Corporation: Revenue Share by Segment, 2023 (%)
Figure 70. Terumo Corporation: Revenue Share by Region, 2023 (%)
Figure 71. Penumbra, Inc.: Net Revenue, 2021-2023 ($Million)
Figure 72. Penumbra, Inc.: Revenue Share by Region, 2023 (%)
Figure 73. Koninklijke Philips N.V.: Net Sales, 2021-2023 ($Million)
Figure 74. Koninklijke Philips N.V.: Revenue Share by Segment, 2023 (%)
Figure 75. Koninklijke Philips N.V.: Revenue Share by Region, 2023 (%)

Companies Mentioned

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Johnson and Johnson
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Clot Management Devices Market by Product, End-User - Global Forecast 2025-2030 - Product Image

Clot Management Devices Market by Product, End-User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Clot Management Devices Market Report by Product Type, End-User, and Region 2024-2032 - Product Image

Clot Management Devices Market Report by Product Type, End-User, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Clot Management Devices Global Market Report 2024 - Product Image

Clot Management Devices Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Clot Management Devices Market Report and Forecast 2024-2032 - Product Image

Clot Management Devices Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Clot Management Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Clot Management Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.